Massachusetts General Hospital (MGH) Psychiatry Academy Child and Adolescent Psychopharmacology Conference 2018
The Westin Copley PlaceBoston, USA Visit the Venue to read more
This renowned conference provides a complete update across research, assessment, and treatment of mental health conditions in children and adolescents. It is ideal if you work in mental health, primary care, nursing, psychology, school health, and more.
Hear guidance on translating new research into clinical practice for substance use disorders, mood disorders, OCD, schizophrenia, anxiety disorders, and more
Find sessions on pharmacologic treatments, psychological interventions, naturopathic treatments, suicide risk and prevention, implications of genetics, and much more
Ask questions and discuss cases during Curbside Consultation hours with experts on specific topics
Find insights that enhance your clinical work in psychiatric practices, community clinics, hospitals, school-based settings, primary care offices, university clinics, and psychology practices
NEW FOR 2018!
Participate in a full-day agenda on ADHD Across the Life Span.
The agenda focuses on diagnosis, treatment and management of ADHD. Topics include:
Neurobiology, genetics and neuroimaging
Treatment of pediatric ADHD
CBT & psychosocial treatments
ADHD and learning disabilities
Treatment of comorbidities
Legal issues in treating ADHD
And much more!
You have two registration options:
Register for the full Child and Adolescent Psychopharmacology conference, which includes ADHD Across the Life Span on Sunday.
Register only for ADHD Across the Life Span with our Sunday-only registration option
At the end of this educational activity, participants should be able to:
Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety.
Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
Recognize the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.
Review the comorbidiy of ADHD with posttraumatic stress disorder and traumatic brain injury.
Explore emotional dysregulation, executive function and learning disorders in the context of ADHD.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Contact No.: (866) 644-7792
Contact No.: (866) 644-7792